| Literature DB >> 29804834 |
Brian T Weinert1, Takeo Narita1, Shankha Satpathy1, Balaji Srinivasan1, Bogi K Hansen1, Christian Schölz2, William B Hamilton3, Beth E Zucconi4, Wesley W Wang5, Wenshe R Liu5, Joshua M Brickman3, Edward A Kesicki6, Albert Lai7, Kenneth D Bromberg7, Philip A Cole4, Chunaram Choudhary8.
Abstract
The acetyltransferases CBP and p300 are multifunctional transcriptional co-activators. Here, we combined quantitative proteomics with CBP/p300-specific catalytic inhibitors, bromodomain inhibitor, and gene knockout to reveal a comprehensive map of regulated acetylation sites and their dynamic turnover rates. CBP/p300 acetylates thousands of sites, including signature histone sites and a multitude of sites on signaling effectors and enhancer-associated transcriptional regulators. Time-resolved acetylome analyses identified a subset of CBP/p300-regulated sites with very rapid (<30 min) acetylation turnover, revealing a dynamic balance between acetylation and deacetylation. Quantification of acetylation, mRNA, and protein abundance after CBP/p300 inhibition reveals a kinetically competent network of gene expression that strictly depends on CBP/p300-catalyzed rapid acetylation. Collectively, our in-depth acetylome analyses reveal systems attributes of CBP/p300 targets, and the resource dataset provides a framework for investigating CBP/p300 functions and for understanding the impact of small-molecule inhibitors targeting its catalytic and bromodomain activities.Entities:
Keywords: A-485; CBP; acetylation; acetylation kinetics; bromodomain; enhancer; gene transcription; mass spectrometry; p300; proteomics
Mesh:
Substances:
Year: 2018 PMID: 29804834 PMCID: PMC6078418 DOI: 10.1016/j.cell.2018.04.033
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582